Effects of Saenghyul-dan (SHD) on the Myelosuppression Induced by 5-Fluorouracil

  • Lee, Gi-Joon (Department of East-West Cancer Center, Dunsan Oriental Hospital of Daejeon University) ;
  • Son, Chang-Gue (Department of East-West Cancer Center, Dunsan Oriental Hospital of Daejeon University) ;
  • Lee, Yeon-Weol (Department of East-West Cancer Center, Dunsan Oriental Hospital of Daejeon University) ;
  • Lee, Nam-Heon (Department of East-West Cancer Center, Dunsan Oriental Hospital of Daejeon University) ;
  • Yun, Dam-Hee (Department of East-West Cancer Center, Dunsan Oriental Hospital of Daejeon University) ;
  • Yoo, Hwa-Seung (Department of East-West Cancer Center, Dunsan Oriental Hospital of Daejeon University) ;
  • Cho, Chong-Kwan (Department of East-West Cancer Center, Dunsan Oriental Hospital of Daejeon University) ;
  • Cho, Jung-Hyo (Department of East-West Cancer Center, Dunsan Oriental Hospital of Daejeon University)
  • Published : 2006.12.30

Abstract

Objective : This study aimed to investigate the effect of SHD on myelosuppression using an animal model for therapeutic evidence supporting clinical positive results. Methods : After determining the optimal concentration of 5-FU as 300 mg/kg for developing the mouse model, ICR mice or BALB/c mice were administered with SHD, and several blood parameters, including hematopoietic cytokines, colony forming activity and histological findings, were examined to evaluate the effects. Results : SHD restored the WBC and hemoglobin, and showed effects on maintaining body weight, producing GM-CSF and IL-3 and stem cell colony forming activity in accordance with histological relative entirety on bone marrow. Conclusion : SHD is an herbal drug having therapeutic effects on myelosuppression. Thus, it could be prescribed to cancer patients undergoing chemo-therapies or radio-therapies in the process of cancer treatment.

Keywords